Özbalak, M. Et Al. 2021. R-CHOP Chemotherapy Including Biosimilar Rituximab (Redditux) for De-Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single Center Experience. 63rd ASH Annual Meeting and Exposition , (Georgia, United States Of America), 4585.

Özbalak, M., Mastanzade, M., Özlük, Ö., Tiryaki, T. O., Erdem, S., Özbalak, E. P., ... Elverdi, T.(2021). R-CHOP Chemotherapy Including Biosimilar Rituximab (Redditux) for De-Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single Center Experience . 63rd ASH Annual Meeting and Exposition (pp.4585). Georgia, United States Of America

Özbalak, Murat Et Al. "R-CHOP Chemotherapy Including Biosimilar Rituximab (Redditux) for De-Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single Center Experience," 63rd ASH Annual Meeting and Exposition, Georgia, United States Of America, 2021

Özbalak, Murat Et Al. "R-CHOP Chemotherapy Including Biosimilar Rituximab (Redditux) for De-Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single Center Experience." 63rd ASH Annual Meeting and Exposition , Georgia, United States Of America, pp.4585, 2021

Özbalak, M. Et Al. (2021) . "R-CHOP Chemotherapy Including Biosimilar Rituximab (Redditux) for De-Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single Center Experience." 63rd ASH Annual Meeting and Exposition , Georgia, United States Of America, p.4585.

@conferencepaper{conferencepaper, author={Murat Özbalak Et Al. }, title={R-CHOP Chemotherapy Including Biosimilar Rituximab (Redditux) for De-Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single Center Experience}, congress name={63rd ASH Annual Meeting and Exposition}, city={Georgia}, country={United States Of America}, year={2021}, pages={4585} }